Literature DB >> 5839555

Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism.

R R Strang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5839555      PMCID: PMC495925          DOI: 10.1136/jnnp.28.5.404

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  1 in total

1.  ACTION OF PRONETHALOL ON PARKINSONIAN TREMOR.

Authors:  A B HERRING
Journal:  Lancet       Date:  1964-10-24       Impact factor: 79.321

  1 in total
  7 in total

1.  Effect of the beta adrenergic blocking agent propranolol on essential tremor.

Authors:  M H Morgan; R L Hewer; R Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

Review 2.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  [Inhibition of tremor by active beta-adrenolytic substances].

Authors:  H Jacobi
Journal:  Naturwissenschaften       Date:  1967-02

4.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Treatment of essential tremor with propranolol.

Authors:  T J Murray
Journal:  Can Med Assoc J       Date:  1972-11-18       Impact factor: 8.262

6.  Use of beta-blocking drugs in psychiatry and neurology.

Authors:  P J Tyrer
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

Review 7.  Beta-blocker therapy for tremor in Parkinson's disease.

Authors:  N J Crosby; K H O Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.